Treatment of lymphomas via regulating the Signal transduction pathways by natural therapeutic approaches: A review

• Published in: Leukemia research 2021-05, Vol.104, p.106554-106554, Article 106554
• Main Authors: Batool, Ammara, Hazafa, Abu, Ahmad, Saeed, Khan, Hamid Ali, Abideen, Hafiz M.Z., Zafar, Ayesha, Bilal, Muhammad, Iqbal, Hafiz M.N.
• Format: Article
• Language: English
• Subjects: Anti-cancer agents; Apoptosis; Bromelain; Cell-proliferation; EGCG; Lymphoma; MK615; Natural products; Resveratrol; Risk factors
• ISSN: 0145-2126; 1873-5835
• DOI: 10.1016/j.leukres.2021.106554

[Display omitted] •Lymphoma counts 4.2 and 3.3 % of all new cancer cases and deaths in 2019, globally.•Natural compounds regulate signaling pathways to exhibit anti-lymphoma activities.•Curcumin reduced the lymphomas (80.97 %) by repressing the activation of STAT-3.•Apoptosis and cell cycle arrest pathways could be regulated by natural products.•Natural approaches could be a good therapeutic option in the treatment of lymphomas. Lymphoma is a heterogeneous group of malignancies, which comprises 4.2 % of all new cancer cases and 3.3 % of all cancer deaths in 2019, globally. The dysregulation of immune system, certain bacterial or viral infections, autoimmune diseases, and immune suppression are associated with a high risk of lymphoma. Although several conventional strategies have improved during the past few decades, but their detrimental impacts remain an obstacle to be resolved. However, natural compounds are considered a good option in the treatment of lymphomas because of their easy accessibility, specific mode of action, high biodegradability, and cost-effectiveness. Vegetables, fruits, and beverages are the primary sources of natural active compounds. The present review investigated the activities of different natural medicinal compounds including curcumin, MK615, resveratrol, bromelain, EGCG, and Annonaceous acetogenins to treat lymphomas. Moreover, in vitro and in vivo studies, classification, risk factors, and diagnosis of lymphoma are also discussed in the present review. The accumulated data proposed that natural compounds regulate the signaling pathways at the level of cell proliferation, apoptosis, and cell cycle to exhibit anti-lymphoma activities both in-vivo and in-vitro studies and suggested that these active compounds could be a good therapeutic option in the treatment of different types of lymphomas.